ArticleNaunyn-Schmiedeberg's archives of pharmacology2025

Pirfenidone mitigates demyelination and electrophysiological alterations in multiple sclerosis: Targeting NF-κB, sirt1, and neurotrophic genes.

Reda A A Abo-Elsoud et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.